Regeneron Pharmaceuticals | 销售和管理费用

股票价格
785.51
每天变化
18.88 2.46%
每月一次
-3.29%
每年
10.64%
Q1 预测
761.39




销售和管理费用 更改 日
AbbVie USD 3.89B 325M 2025-12
Agios Pharmaceuticals USD 41.27M 4.6M 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Amgen USD 1.94B 237M 2025-12
Astellas Pharma JPY 221.78B 14.94B 2025-12
AstraZeneca USD 148M 4.86B 2025-09
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Gilead Sciences USD 1.35B 6M 2025-09
GlaxoSmithKline GBP 2.68B 518M 2025-12
Incyte USD 329.08M 1.94M 2025-09
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
J&J USD 6.75B 831M 2025-12
Kyowa Hakko Kirin JPY 38.72B 2.06B 2025-09
Merck USD 2.85B 215M 2025-12
Moderna USD 268M 38M 2025-09
Neurocrine Biosciences USD 291.6M 5.3M 2025-09
Novartis USD 3.31B 134M 2025-09
Novartis USD 3.3B 137M 2025-09
Pfizer USD 4.08B 894M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.75B 455M 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
United Therapeutics USD 152M 60.5M 2025-09
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09


Regeneron Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.